Jazz Pharmaceuticals plc earnings per share and revenue

JAZZ earnings per share for the last quarter are 6.61 USD whereas the estimation was 5.50 USD which accounts for 20.22% surprise. Company revenue for the same period amounts to 1.05 B USD despite the estimated figure of 1.04 B USD. Estimated earnings per share for the next quarter are 5.79 USD, and revenue is expected to reach 1.06 B USD. Also watch annual changes over time to get a bigger picture of JAZZ earnings per share and revenue dynamics.